FREE DiButyl Phthalate Lawsuit Questionnaire
Weitz & Luxenberg P.C. is no longer accepting DiButyl Phthalate cases. However, to get a free legal review about another matter, or have your legal questions answered, please fill out the questionnaire below. We will be in touch shortly.
Our Drug and Medical Device Litigation unit has won numerous cases involving dangerous pharmaceuticals, including Vioxx, achieving a $13.5 million verdict against Merck & Co. The firm’s other active pharmaceutical litigations include actions against the manufacturers of Bextra, ReNu, Celebrex, Ortho Evra, Gadolinium dye and Medtronic's Sprint Fidelis Leads.
see also:
Research Center
Dibutyl Phthalate Research Information from Experienced LawyersFREE Dibutyl Phthalate Research from Weitz & Luxenberg lawyers
Free Legal Review
DiButyl Phthalate Lawsuit - Free Legal Review DiButyl Phthalate Lawsuit - Free Legal Review on dangerous chemical
DiButyl Phthalate
What you should know about DiButyl PhthalateFind out the dangers of DiButyl Phthalate, a compound in nail polish


